Arthur P. Bertolino

3.0k citations
20 papers · 1.8k indexed · 1 hit paper · h-index 12

Arthur P. Bertolino

20 papers receiving 1.7k citations

Hit Papers

Secukinumab, a human anti-IL-17A monoclonal antibody, for...1.2k20122026201620212505007501000

Peers

Arthur P. Bertolino
Comparison fields: 5 of 104
  • Immunology 1.0k
  • Urology 197
  • Rheumatology 433
  • Dermatology 235
  • Hematology 290
Replace Miloš Nikolić with:
Miloš Nikolić Serbia
R Touraine France
Vivek S. Purohit United States
T. E. Cawston United Kingdom
Jan E. Ehlert Germany
Sandra Garcet United States
Anthony du Vivier United Kingdom
Henri Montaudié France
Sergio Chimenti Italy
P Lipponen Finland
Arthur P. Bertolino relative to Miloš Nikolić Serbia Miloš Nikolić's profile →
Citations per field
00.5×5.6×
Miloš Nikolić · 1×
Citations per year

Countries citing papers authored by Arthur P. Bertolino

Since Specialization
Citations

This map shows the geographic impact of Arthur P. Bertolino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur P. Bertolino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur P. Bertolino more than expected).

Fields of papers citing papers by Arthur P. Bertolino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur P. Bertolino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur P. Bertolino. The network helps show where Arthur P. Bertolino may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Arthur P. Bertolino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arthur P. Bertolino Line = papers co-authored together Arthur P. Bertolino links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 2013272
2
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trialbreakdown →
20121156
3 200018
4 20008
5 19963
6 199333
7 199369
8 19933
9 199120
10 199124
11 199126
12 19912
13 199046
14 198839
15 19881
16 19881
17 19829
18 19797
19 197817
20 197821

About Arthur P. Bertolino

Arthur P. Bertolino is a scholar working on Urology, Dermatology and Cell Biology, having authored 20 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hair Growth and Disorders (14 papers), Skin and Cellular Biology Research (9 papers), melanin and skin pigmentation (5 papers), Dyeing and Modifying Textile Fibers (4 papers), Dermatologic Treatments and Research (4 papers), RNA regulation and disease (2 papers), Skin Protection and Aging (2 papers) and Genetic and rare skin diseases. (2 papers). The work is most often cited by research in Immunology (1.0k citations), Urology (197 citations) and Rheumatology (433 citations). Arthur P. Bertolino has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Wolfgang Hueber, Stephan Bek, Marc Vandemeulebroecke, Brian G. Feagan, Simon Travis, Jan Wehkamp, Marek Karczewski, Peter Higgins, Walter Reinisch and Gervais Tougas.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026